Twist-1 regulates the miR-199a/214 cluster during development by Lee, Youn-Bok et al.
Published online 23 November 2008 Nucleic Acids Research, 2009, Vol. 37, No. 1 123–128
doi:10.1093/nar/gkn920
Twist-1 regulates the miR-199a/214 cluster
during development
Youn-Bok Lee
1, Ioannis Bantounas
1, Do-Young Lee
1, Leonidas Phylactou
2,
Maeve A. Caldwell
1 and James B. Uney
1,*
1The Henry-Wellcome Laboratories for Integrated Neuroscience and Endocrinology, University of Bristol, Dorothy
Hodgkin Building, Whitson Street, Bristol, BS1 3NY, UK and
2The Cyprus Institute of Neurology and Genetics,
6 International Airport Avenue PO Box 3462, 1683 Nicosia, Cyprus
Received July 20, 2008; Revised October 10, 2008; Accepted November 1, 2008
ABSTRACT
MicroRNAs are known to regulate developmental
processesbuttheirmechanismofregulationremains
largely uncharacterized. We show the transcription
factor Twist-1 drives the expression of a 7.9-kb
noncoding RNA transcript (from the Dynamin-3
gene intron) that encodes a miR-199a and miR-214
cluster. We also show that knocking down Twist-1
with shRNAs decreased miR-199a/214 levels and
that Twist-1 bound an E-Box promoter motif to
developmentally regulate the expression of these
miRNAs. The expression of HIF-1 (known to mediate
Twist-1 transcription), miR-199a and miR-214 was
maximal at E12.5 and the miRNAs were expressed
specifically in mouse cerebellum, midbrain, nasal
process and fore- and hindlimb buds. This study
shows the expression of the miR199a/214 cluster is
controlled by Twist-1 via an E-Box promoter element
and supports a role for these miRNAs as novel inter-
mediates in the pathways controlling the develop-
ment of specific neural cell populations.
INTRODUCTION
MicroRNAs (miRNA) bind the 30-untranslated region
(UTR) of mRNAs and elicit translational repression or
mRNA cleavage and this action represents an entirely
new level of post-transcriptional regulation. More than
500 human miRNAs together with some of their mRNA
targets have now been identiﬁed empirically and it is clear
that they act to govern fundamental cellular pathways
controlling development, cancer and apoptosis (1,2).
Although miRNAs are now known to be key regulators
of gene expression, the pathways controlling the expres-
sion of individual miRNA genes are only beginning to be
elucidated. For example, recently, the transcription of
miR-146a during development was shown to be sup-
pressed by promyelocytic leukemia zinc-ﬁnger (PLZF)
protein (3,4); the transcription factor GATA-1 was
shown to drive the expression of a single transcript
encoding miR-144 and miR-451 during zebra ﬁsh devel-
opment (5). While investigating the control of miR-214
expression we found that the miR-199a and miR-214
genes are located  6kb apart within the intron of the
dynamin-3 gene and that Twist-1 had previously been
reported to drive the expression of a single noncoding
transcript from this region (6). Twist is a nuclear basic
helix–loop–helix (bHLH) transcription factor known to
be crucial for mesoderm formation in Drosophila (7).
In mammals, Twist-1 is expressed in cranial neural crest
derivatives and in mesenchymal structures (8–11).
Mutations in the Twist-1 gene cause the Saethre-
Chotzen syndrome, an autosomal dominant craniosynos-
tosis characterized by abnormal fusion of the cranial
sutures (12,13). Studies have also indicated that Twist
family members bind preferentially to E-box DNA
promoter sequences as homodimers (14) or heterodimers
(15). We present data to show that during embryonic
development Twist-1 binds an E-box region within the
DNM-3 gene intron to drive the expression of a single
transcript that is processed to miR-199a and miR-214.
MATERIALS AND METHODS
Generationof recombinant adenovirus constructs
Mouse Twist-1 cDNA was cloned into the PxCx-CMV
shuttle vector and recombinant E1-deleted adenoviral
constructs produced as described previously (16). The pre-
dicted DNM3os promoter was recovered from mouse
genomic DNA by PCR. The primer sequences were: pro-
moter (–640:0) forward (F), AAA GGG GGG AGC CCC
AAC TTA TCT G; reverse (R), TTC CTG CAC CAG
GGG CTT GT; E-box deleted (–640:-357) forward, AGG
GGG GAG CCC CAA CTT ATC TGA; reverse, TGG
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cloned into PCR2.1 plasmids using a TOPO cloning kit
(Invitrogen) and the plasmid sequenced. The promoter
sequences were ﬁnally subcloned into PGL2 Luciferase
reporter plasmids (Promega).
RNA isolation andRT-PCR
Whole embryos were collected from time mated C57Bl6
mice at the embryonic stages (E) 10.5, 11.5, 12.5, 14.5 and
16.5 (plug day was E0.5, B&K, UK). Total RNA and
miRNA was extracted from embryos and N2A cells
using RNeasy mini (Qiagen) or miRNA extraction kit
(Ambion), respectively. RT-PCR for the analysis of gene
expression was performed on 500ng of RNA and cDNA
synthesis was carried out using SuperscriptIII
(Invitrogen). RT-PCR analysis of the DNM3, Dynamin-
3 opposite strand (DNM3os) and GAPDH gene expres-
sion was performed using previously described primer
sequences (6). Optimized HIF-1 and Twist-1 primers
were designed using the vector NTI program
(Invitrogen). The primer sequences for RT-PCR were:
DNM3, (F) CCG AGA CTT AAT TCC AAA ACA
ATA ATG; DNM3 (R), AAA GGA GTC ACT GCT
GTT GGG AAA A; DNM3os, (F) GGT CTC ACC
CTG CTT GTT AAT CAA GGG GGA; DNM3os, (R)
TCC TGT TGT TAC TGG CCC TCA TGC AGC C;
GAPDH (F), ACC ACA GTC CAT GCC ATC TC;
GAPDH (R), TCC ACC ACC CTG TTG CTG TA;
HIF-1 (F), TGA GCG TTT CCT AAT CTC AT; HIF-1
(R), AGC GAC AAA GTG CAT AAA AC; Twist-1 (F),
CGA CGA CAG CCT GAG CAA CA; Twist-1 (R), TGC
AGC TCC TCG TAC GAC TG. PCR was carried out at
948C for 45s, 608C for 45s and 728C for 1min for 25
cycles, using high-ﬁdelity Taq polymerase (Roche).
Parallel ampliﬁcations were performed on the templates
from which the reverse transcriptase was omitted to
ensure that ampliﬁcation was dependent on the presence
of single strand of cDNA.
Westernblot
All primary antibodies were diluted in PBS with 5% (v/v)
Blocking solution (Roche). The mouse anti-Twist1
(AbCam) Ab was used at a 1:1000 dilution and the
mouse anti-a-Tubulin (Sigma) at 1:1000. In all cases, cor-
responding horseradish peroxidase-linked antibodies were
used (Amersham).
RNA isolation andmiRNA detection
Small RNAs were isolated using the mirVana miRNA
Isolation Kit (Ambion). miRNA expression levels were
assessed using Taqman MiRNA Assays (Applied
Biosystems) according to the manufacturer’s protocol.
Results were normalized against levels of RNU6B (as
assessed by the corresponding Taqman Assay; Applied
Biosystems); 10ng of total RNA were used as the template
for the RT reaction in each case.
Luciferase reporter assay
Cells (at 50% conﬂuence) in 24-well plates were trans-
fected using lipofectamine (Invitrogen) mixed with a
Fireﬂy luciferase reporter gene construct (200ng). Cell
extracts were prepared 48h after transfection and the luci-
ferase activity was measured using the Luciferase Reporter
Assay System (Promega).
Whole-mount insitu hybridization
DIG (digioxigenin) labeled DNM3os antisense RNA
probes were generated from RT-PCR derived templates
by in vitro transcription. In order to produce a DNA tem-
plate for the generation of antisense RNA probes by
in vitro transcription, T7 RNA polymerase promoter
sequences were added to the 50end of the PCR product.
The primer sequences used are shown below (promoter
sequences are in bold): DNM3os (F), GGT CTC ACC
CTG CTT GTT AAT CAA GGG GGA, DNM3os (R):
GCA GTA ATA CGA CTC ACT ATA GGG TCC TGT
TGT TAC TGG CCC T CA TGC AGC C. One hundred
nanograms of template DNA was used for in vitro tran-
scription using a DIG-labeling kit (Roche). Pre DIG
labeled LNA miR-199a-5p, miR-199a-3p, mir-214 and
scrambled control probes were purchased from Exiqon.
In situ hybridization with DIG probes and detection
with alkline-phosphatase-conjugated antibodies were car-
ried out as described previously (17).
RESULTS
Twist-1 drives theexpression ofmiR-199a/214
The miR-199a/214 gene cluster is located in the opposite
(30–50) direction to the DNM-3 gene suggesting it is tran-
scribed from its own promoter (Figure 1). Furthermore, it
was predicted previously that the expression of a (non-
coding) 7.9-kb Dynamin-3 opposite strand (DNM3os)
during development may be under the control of Twist-
1(6). Hence, we investigated whether Twist-1 drives
the expression of DNM3os, miR-199a and miR-214
Figure 1. The miR-199a/214 cluster lies within the DNM3 gene. A
schematic diagram of the Dynamin3 gene showing the complementary
strand within its intron encodes a single transcript (DNM3os). The
inset ﬁgure shows the DNM3os transcript encodes miR-199a and
miR-214 and that an E-Box promoter drives transcription in a reverse
orientation.
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novirus to over-express Twist-1 in N2a neuroblastoma
cells and found that DNM3os expression was increased
5- to 6-fold above control levels (Figure 2A). Further
RT-PCR experiments then showed that Twist-1 expres-
sion also mediated a 5-fold increase in both miR-214
and miR-199a expression (Figure 2B).
NIH-3T3 embryonic ﬁbroblasts express Twist-1 consti-
tutively and we therefore used this cell line to investigate
whether Twist-1 regulates miR-199a and miR-214 under
normal physiological circumstances. Western blotting and
quantitative PCR conﬁrmed that Twist-1 (Figure 3A) and
the noncoding RNA DNM3os (Figure 3B) were expressed
in NIH-3T3 cells, respectively. To investigate whether
under normal physiological conditions Twist-1 was
responsible for driving miR-199a and miR-214 expression
we used an anti-Twist1 shRNA construct (kindly provided
by Dr. Michael C. Naski). The Taqman results showed
that anti-Twist-1 shRNA decreased the expression of
miR-214 and miR-199a expression while the scrambled
shRNA control did not (Figure 3C).
Twist-1 acts on an E-Box todrive miR-199a/214 expression
Having conﬁrmed Twist-1 was driving miR-214 and miR-
199a expression we searched for promoter motifs and
noted that a region containing an E-Box (a promoter ele-
ment known to be bound by Twist-1) was present. This
region (–640 to 0bp of the DNM3os) was isolated from
genomic DNA by PCR and cloned next to a luciferase
reporter gene (Figure 4A). Further, we also deleted the
basic-helix–loop–helix (bHLH)-binding E-box element
(CATCTG) known to be essential for Twist-1 transcrip-
tional activity (and also cloned this next to a luciferase
reporter gene). The results of reporter assays showed
that luciferase activity was increased by Twist-1 in cells
transfected with the E-Box-luciferase construct (–640:0);
however, no increase in luciferase activity was observed
Figure 4. Promoter assays showing Twist-1 mediates expression via the
E-box region. (A) Schematic diagram together with an agarose gel
showing the entire (–640 to 0bp) promoter and E-Box deleted promoter
region of DNM3os. (B) Luciferase Promoter assays show that Twist-1
drives expression via the E-Box region (–640:0) within the DNM3os
transcript. Promoter activity is at background levels when the E-Box is
deleted (–640:357) and when cells are transduced with control vectors.
Figure 2. Twist-1 mediates the expression a single antisense transcript
encoding miR-199a and miR-214. (A) Western blot and agarose gel
showing that Twist-1 and the DNM3os transcript are expressed respec-
tively in N2a cells when they are transduced with Ad.Twist-1. (B)
Q-PCR analysis also shows that the expression of miR-199a and
miR-214 are signiﬁcantly increased (P<0.001 by t-test in both cases)
following transduction with Ad.Twist-1.
Figure 3. ShRNA mediated knockdown of Twist-1 results in decreased
miR-199a and miR-214 expression. Western blotting (A) and QPCR
analysis (B) show that Twist-1 and DNMO3 is constitutively expressed
in NIH-3T3 cells. (C) Inhibiting Twist-1 expression by transfecting cells
with an anti-Twist-1 shRNA resulted in a >2-fold decrease in the levels
of miR-199a and miR-214 (n=3 in all cases).
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lacking the E-box (Figure 4B).
We next sought to conﬁrm that Twist-1 expression
during development coincided with that of DNM3os,
miR-214 and miR-199a and we analyzed transcript
expression at E10.5, E12.5, E14.5 and E16.5. Figure 5A
shows that DNM3os mRNA levels were ﬁrst expressed
at E10.5, were maximal at E12.5 and began to decrease
at E14.5. The sense DNM3 mRNA transcript was also
detected from E12.5 onward (Figure 5A). Western and
QT-RTPCR showed that the expression of the Twist-1
transcription factor and mRNA, respectively, was also
maximal at E12.5 and decreased at E14.5 (Figure 5B).
HIF-1 has been shown to directly regulate Twist-1 expres-
sion (18,19) and we also showed that HIF-1 mRNA
expression corresponded closely with that of Twist-1
being expressed maximally at E12.5 (Figure 5B).
Furthermore, Taqman analyses showed that the expres-
sion of miR-199a-5p, miR-199a-3p and miR-214 levels
were highest at E12.5 and this corresponded with peak
DNM3os and Twist-1 expression (Figure 6A). Finally,
we used in situ hybridization to observe the expression
of the single-stranded DNM3os, miR-199a-3p, miR-
199a-5p and miR-214. The results showed that DNM3os
was strongly expressed in the cerebellum, midbrain, nasal
process and fore- and hindlimb buds and that expression
of miR-214 mirrored that of DNM3os. However, miR-
199a-3p was most strongly expressed in the hindbrain,
while miR-199a-5p was strongly expressed in the limb
buds (Figure 6B).
DISCUSSION
It was observed previously that a noncoding 7.9-kb
DNM3os fragment is expressed during development and
that its expression may be under the control of Twist-1(6).
Here we present promoter deletion studies to show
that the bHLH transcription factor Twist-1 drives the
expression of the 7.9-kb antisense transcript via an
E-Box within the Dynamin-3 gene intron and that the
transcript encodes the miR-199a and miR-214 genes. In
addition, we show that inhibiting the expression of Twist-
1 resulted in decreased miR-199a and miR-214 levels, indi-
cating that under normal physiological conditions Twist-1
can drive the expression of the miR-199a/214 cluster. We
further show that mir-199a and mir-214 are developmen-
tally regulated, with expression beginning at E11.5, being
maximal at E12.5 and falling at E14.5. The expression of
the transcription factor HIF1 (known to drive the expres-
sion of Twist-1) Twist-1, and miR-199a and miR-214
were coincident during development. Together, these
data strongly suggest that Twist-1 drives DNM3os, miR-
199a and miR-214 expression during development.
Furthermore, in situ studies on E12.5 embryos showed
that the miRNAs were expressed speciﬁcally in mouse
cerebellum, midbrain, nasal process and fore and hind
limb buds.
Previous studies have examined the role of miRNAs in
ES cells and embryonic development by knocking out the
enzymes (Dicer, Drosha and DGCR8) that are involved in
miRNA biogenesis. These studies have revealed a crucial
role for miRNAs in ES cell diﬀerentiation, and the control
of development (20). MiRNA-speciﬁc studies have
shown that miR-214 regulates the speciﬁcation of zebra
ﬁsh muscle cell types by targeting a negative regulator of
Hedgehog signaling (21) and miR-199a has been
shown to regulate COX-2 expression in mouse uterus
during implantation (22). We have previously shown
that during establishment of the brain coronal suture,
Twist-1 knockout results in abnormal cell proliferation
and osteoblast diﬀerentiation. Results that suggest
Figure 5. DNM3os, DNM3, HIF-1 and Twist-1 are expressed together
during development. The expression of DNM3os, DNM3 (A) and Hif1
and Twist-1 (B) was measured in the whole-cell embryo by RT-PCR
at various stages of embryonic development. Western blot showing
Twist-1 protein expression at the diﬀerent stages of development is
also shown (C).
126 Nucleic Acids Research, 2009, Vol. 37, No. 1miR-199a and mir-214 may play a role in mediating
coronal sutural formation (13). Together, these results
support a role for miR-199a/214 in specifying cell fate
during embryonic development. MiRBase shows that
there are three genomic loci for the miR-199a gene and
only one for miR-214 within the DNM-3 intron. It is
therefore possible that Twist-1 expression will be found
to be associated with miR-214 expression in adult tissues.
Interestingly, the altered expression of miRNAs and
Twist-1 in mature tissues is known to lead to changes in
the expression of cell cycle proteins and tumorigenesis
(23,24). Such studies have shown that miR-214 induces
cell survival and cisplatin resistance via the control of
PTEN expression and subsequent activation of the Akt
pathway. MiR-199a targets the 30UTR of the Met
proto-oncogene and its expression results in the down-
regulation of Met and its down stream target ERK2
(22). Furthermore, the expression of miR-214 and miR-
199a have been shown to mirror each other in human
epithelial ovarian cancer tissue (24,25), and human solid
cancer tissues (26). Signiﬁcantly, Twist-1 expression has
also been shown to play a role in tumour development,
progression and survival (27). Together, these data suggest
that miR-199a and miR-214 sculpt developmental pro-
cesses by mediating eﬀects on cell cycle proteins.
Furthermore, it will be important to investigate whether
that the ectopic expression of miR-199a/214 during tumir-
ogenesis is due to aberrant Twist-1 expression.
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